New Platform Expected to Make Whole Genome Sequencing Significantly More Affordable and Accessible for Use in Mainstream Medical Care MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences…
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms,…
MENLO PARK, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (the “Company”) (NASDAQ: PACB), a leading provider of high-quality sequencing platforms, today announced unaudited preliminary revenue…
MENLO PARK, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the appointments of Mark Van…
Seven New Sequel IIe Systems Will Support Expanded Generation of High-Quality Genomes for Improving Fundamental Understanding of Biology and Aiding Biodiversity Conservation MENLO PARK, Calif ., Jan. 08, 2021 (GLOBE…
MENLO PARK, Calif., Dec. 18, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes,…
Presentation at the American Society for Microbiology NGS Conference Highlights Utility of PacBio’s Highly Accurate Long-Read Sequencing Platform in Disease Surveillance MENLO PARK, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) —…
Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research Have Added New PacBio Sequel II & IIe Systems to Their Service Laboratories MENLO PARK, Calif., Dec….
MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced…
MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of…
MENLO PARK, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2020. Third Quarter…
SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider…
MENLO PARK, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2020 Financial Results…
Collaboration Will Utilize PacBio’s Highly Accurate HiFi Sequencing to Solve Rare Pediatric Genetic Diseases That Have Proven Intractable in Previous Studies KANSAS CITY, Mo., and MENLO PARK, Calif., Oct. 15,…
New System Features Advanced On-Instrument Data Processing and Cloud Enablement to Deliver HiFi Data Faster and With Significant Reduction in Compute and Data Storage Costs MENLO PARK, Calif., Oct. 05,…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.